About four dozen children who attended a community party in August 2025 later developed skin and soft tissue lesions and ...
The Trump administration is promising to send $500 refund checks to nearly 1 million people with Affordable Care Act health ...
UniQure readout tests durability of benefits, an AI effort to manage heart failure, and more biotech news from The Readout ...
Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and more
A major Novartis shareholder has called for a shake-up of the drugmaker's board after its shares suffered a record fall ...
Platinum chemotherapy aged the liver cells of treated children, making them look more like adult liver cells and possibly ...
The pharma industry invested billions of dollars to develop drugs heralded as the next era in the treatment of heart disease ...
There has been rancorous debate over doctors accepting free gifts and speaking fees from pharma companies. That doesn't mean ...
The two measles-related deaths in Pennsylvania last month involved infants, and the virus itself caused one of the deaths, a ...
Before the end of September, UniQure is expected to report four-year results from the closely tracked clinical trial of its ...
A U.K. commission has unveiled its recommendations for how the country should regulate artificial intelligence in medicine.
Feds invest in AI for heart failure, vaccines and this year's midterms, and more health news from Morning Rounds ...
Nothing in the recent reporting about John Fetterman is medically surprising,” write Michael P.H. Stanley and Isaiah Kletenik.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results